[Use of glaucoma medications during pregnancy and breastfeeding]

Arch Soc Esp Oftalmol. 2012 Dec;87(12):389-91. doi: 10.1016/j.oftal.2012.10.005.
[Article in Spanish]
No abstract available

Publication types

  • Editorial

MeSH terms

  • Abnormalities, Drug-Induced / prevention & control
  • Administration, Ophthalmic
  • Administration, Oral
  • Adrenergic beta-Antagonists / administration & dosage
  • Adrenergic beta-Antagonists / adverse effects
  • Adrenergic beta-Antagonists / therapeutic use*
  • Animals
  • Brimonidine Tartrate
  • Carbonic Anhydrase Inhibitors / administration & dosage
  • Carbonic Anhydrase Inhibitors / adverse effects
  • Carbonic Anhydrase Inhibitors / therapeutic use*
  • Contraindications
  • Female
  • Fetus / drug effects
  • Gels
  • Glaucoma / drug therapy*
  • Glaucoma / physiopathology
  • Glaucoma / surgery
  • Humans
  • Hypotension / chemically induced
  • Intraocular Pressure
  • Lactation*
  • Obstetric Labor, Premature / prevention & control
  • Ophthalmic Solutions
  • Pregnancy
  • Pregnancy Complications / drug therapy*
  • Pregnancy Complications / physiopathology
  • Pregnancy Complications / surgery
  • Prostaglandins / therapeutic use
  • Quinoxalines / adverse effects
  • Quinoxalines / therapeutic use
  • Timolol / administration & dosage
  • Timolol / adverse effects
  • Timolol / therapeutic use

Substances

  • Adrenergic beta-Antagonists
  • Carbonic Anhydrase Inhibitors
  • Gels
  • Ophthalmic Solutions
  • Prostaglandins
  • Quinoxalines
  • Brimonidine Tartrate
  • Timolol